Sather Financial Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Sather Financial Group's PFE Position: Q1 2026 in Review
Sather Financial Group reduced its Pfizer (PFE) stake by 6.2% in Q1 2026, selling an estimated $17.4K and leaving 9,945 shares worth $279K. The position accounts for 0.02% of the portfolio, ranked #86.
Sather Financial Group first reported a position in PFE in Q1 2022 and has held it in 17 quarters since. The position peaked at $729K in Q2 2022. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Sather Financial Group held 9,945 shares of Pfizer worth $279K as of Q1 2026.
- Sather Financial Group sold 653 Pfizer shares in Q1 2026, an estimated $17.4K.
- Pfizer made up 0.02% of Sather Financial Group's portfolio in Q1 2026, its #86 holding.
- Sather Financial Group first reported a position in Pfizer in Q1 2022 and has held it in 17 quarters since.
- Sather Financial Group's Pfizer position peaked at $729K in Q2 2022.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Sather Financial Group's 13F filing for Q1 2026, filed 29 Apr 2026.